Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed study objectives and endpoints related to a clinical trial for biliary tract cancer, while adding new terminology and a revision number.
    Difference
    53%
    Check dated 2025-04-16T01:43:46.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T20:17:54.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T15:19:58.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:03:53.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-03T18:03:38.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T15:59:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.